KILLA EXTRA STRENGTH 2 PACK- salicylic acid patch
ZitSticka, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ZSK Killa ES 2 pk pouch drug facts

Ask a doctor if irritation become severe.

Keep out of reach of children. If swallowed, get medical help or contact a posion Control Center right away.

Uses:

For the management of acne.
Penetrates pores to eliminate most blemishes.

inactive ingredients

directions

For External Use only

indications

warnings

ZitSticka Killa ES 2 pk pouch pdp

ZSK Killa ES 2pk pouch

KILLA EXTRA STRENGTH 2 PACK
salicylic acid patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:81746-526
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.0125 mg in 0.6216 mg

Ingredient Name	Strength
Inactive Ingredients
4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)
PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)
GLYCOLIC ACID (UNII: 0WT12SX38S)
OLIGOPEPTIDE-10 (UNII: Q46328TRNK)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
MADECASSOSIDE (UNII: CQ2F5O6YIY)
NIACINAMIDE (UNII: 25X51I8RD4)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:81746-526-01	1660 mg in 1 POUCH; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)	05/26/2023

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph final	M006	05/26/2023

Labeler - ZitSticka, Inc. (117778611)

Name	Address	ID/FEI	Business Operations
Establishment
Raphas		695914964	manufacture(81746-526)

Revised: 5/2023

Document Id: fc9922ba-5165-5837-e053-6294a90a3de5

Set id: fc9922ba-5164-5837-e053-6294a90a3de5

Version: 1

Effective Time: 20230526

ZitSticka, Inc.